ListarArtículos (Medicina) por materia "JAK inhibitors"
Mostrando ítems 1-1 de 1
-
Artículo
Treatment of atopic dermatitis with abrocitinib in real practice in Spain: efficacy and safety results from a 24-week multicenter study
(Wiley, 2024)Background Abrocitinib, a selective JAK 1 inhibitor, was recently approved in Europe. Despite its approval, real-world ...